{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:40:26Z","timestamp":1790106026911,"version":"4.0.1"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1111\/j.1572-0241.2008.02129.x","type":"journal-article","created":{"date-parts":[[2008,9,4]],"date-time":"2008-09-04T12:17:04Z","timestamp":1220530624000},"page":"2443-2445","source":"Crossref","is-referenced-by-count":8,"title":["Chemoprevention and Barrett's Esophagus: Decisions, Decisions"],"prefix":"10.14309","volume":"103","author":[{"given":"Gary W.","family":"Falk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janusz","family":"Jankowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1111\/j.1572-0241.2008.02129.x-BIB1","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/jnci\/dji024","article-title":"The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence","volume":"97","author":"Pohl","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/j.1572-0241.2008.02129.x-BIB2","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1572-0241.2008.01790.x","article-title":"Management of Barrett's oesophagus in the UK: Over treated, and under biopsied but improved by a national randomized trial","volume":"103","author":"Das","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1572-0241.2008.02129.x-BIB3","unstructured":"3.\u2002National Cancer Institute. Decline in cancer death rate accelerating. Available at: http:\/\/www.cancer.gov\/ncicancerbulletin\/nci_cancer_bulletin_102307. Accessed June 19, 2008."},{"key":"10.1111\/j.1572-0241.2008.02129.x-BIB4","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/gut.2004.063685","article-title":"Increasing incidence of Barrett's oesophagus in the general population","volume":"54","author":"van Soest","year":"2005","journal-title":"Gut"},{"key":"10.1111\/j.1572-0241.2008.02129.x-BIB5","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1365-2036.2007.03582.x","article-title":"Mortality rates in patients with Barrett's oesophagus","volume":"27","author":"Moayyedi","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1572-0241.2008.02129.x-BIB6","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1053\/gast.2002.31599","article-title":"Esophageal adenocarcinoma arising from Barrett's metaplasia has regional variations in the West","volume":"122","author":"Jankowski","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1572-0241.2008.02129.x-BIB7","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1158\/1078-0432.CCR-06-1104","article-title":"Progress in chemoprevention drug development: The promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer-a plan to move forward","volume":"12","author":"Kelloff","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1111\/j.1572-0241.2008.02129.x-BIB8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/ncpgasthep0412","article-title":"A methodological analysis of chemoprevention in the gastrointestinal tract","volume":"3","author":"Jankowski","year":"2006","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1111\/j.1572-0241.2008.02129.x-BIB9","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMe078044","article-title":"Aspirin and colon cancer-targeting prevention?","volume":"356","author":"Markowitz","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1572-0241.2008.02129.x-BIB10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/gast.2003.50008","article-title":"Protective association of aspirin\/NSAIDs and esophageal cancer: A systematic review and meta-analysis","volume":"124","author":"Corley","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1572-0241.2008.02129.x-BIB11","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S1470-2045(05)70431-9","article-title":"Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: A prospective study","volume":"6","author":"Vaughan","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1111\/j.1572-0241.2008.02129.x-BIB12","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1053\/gast.2002.32371","article-title":"Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus","volume":"122","author":"Buttar","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1572-0241.2008.02129.x-BIB13","doi-asserted-by":"crossref","DOI":"10.1111\/j.1572-0241.2008.02117.x","article-title":"Patient preferences for the chemoprevention of esophageal adenocarcinoma in Barrett's esophagus","author":"Hur","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1572-0241.2008.02129.x-BIB14","article-title":"COX-2's, confirmation of cardiovascular and cancer risk\/benefit ratio: Better the devil you know","author":"Jankowski","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1111\/j.1572-0241.2008.02129.x-BIB15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7326\/0003-4819-136-2-200201150-00016","article-title":"Aspirin for the primary prevention of cardiovascular events: A summary of the evidence for the U.S. Preventive Services Task Force","volume":"136","author":"Hayden","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1572-0241.2008.02129.x-BIB16","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1572-0241.2008.01835.x","article-title":"Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus","volume":"103","author":"Wang","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1572-0241.2008.02129.x-BIB17","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.gastro.2005.05.055","article-title":"The perception of cancer risk in patients with prevalent Barrett's esophagus enrolled in an endoscopic surveillance program","volume":"129","author":"Shaheen","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1572-0241.2008.02129.x-BIB18","first-page":"A37","article-title":"A randomized, multicenter, sham-controlled trial of radiofrequency ablation for subjects with Barrett's esophagus containing dysplasia: Interim results of the AIM dysplasia trial","volume":"134","author":"Shaheen","year":"2008","journal-title":"Gastroenterology"}],"container-title":["The American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000434-200810000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:45:15Z","timestamp":1786542315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-200810000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,10]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1572-0241.2008.02129.x","relation":{},"ISSN":["0002-9270","1572-0241"],"issn-type":[{"value":"0002-9270","type":"print"},{"value":"1572-0241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}